Join to View Full Profile
901 W Main StMedical Arts BuildingFreehold, NJ 07728
Phone+1 732-462-3302
Fax+1 732-780-6213
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kenneth Tomkovich, MD is a board certified radiologist in Freehold, New Jersey. He is currently licensed to practice medicine in New Jersey and Colorado.
Education & Training
University of ColoradoFellowship, Vascular and Interventional Radiology, 1998 - 1999
Rutgers Health/New Jersey Medical SchoolResidency, Radiology-Diagnostic, 1994 - 1998
Jersey Shore University Medical CenterInternship, Transitional Year, 1993 - 1994- Rutgers New Jersey Medical SchoolClass of 1993
Certifications & Licensure
NJ State Medical License 1995 - 2027
CO State Medical License 1998 - 1999
American Board of Radiology Interventional Radiology and Diagnostic Radiology
Publications & Presentations
PubMed
- 9 citationsCryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.Richard E Fine, Richard C Gilmore, Kenneth R Tomkovich, Jill R Dietz, Michael P Berry
Annals of Surgical Oncology. 2024-10-01 - 2 citationsCryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study.Karim Oueidat, Grayson L Baird, Belinda Barclay-White, Kamilia Kozlowski, Michael J Plaza
AJR. American Journal of Roentgenology. 2024-09-01 - 12 citationsBreast Cancer Cryoablation Fundamentals Past and Present: Technique Optimization and Imaging Pearls.Monica L Huang, Kenneth Tomkovich, Deanna L Lane, Rajani Katta, Rosalind P Candelaria
Academic Radiology. 2023-10-01
Press Mentions
IceCure’s ProSense for Cryoablation Treatment of Breast Tumors Evaluated in Six StudiesOctober 7th, 2024- IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free RateSeptember 24th, 2024
- IceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual MeetingNovember 30th, 2022
- Join now to see all
